Main Menu

Venture Capital, 'Term Sheets' and a Road Map of the Material Terms of a Transaction

Finance & Accounting for Bioscience Companies (New Brunswick, NJ) | September 27, 2017

Pivotal changes, from a political, regulatory, economic and strategic perspective, are recasting the life sciences landscape. For growing and emerging biotech companies, either readying for commercial launch or adapting to maturing brands, CFOs, Corporate Controllers and Accounting and Finance executives must reach new
heights in corporate strategy, effectiveness, responsibility and accountability. This tailored event drives practice alignment and shares best practices with perspectives from leading industry professionals.  

Ryan Udell, Co-Chair of the Corporate and Securities Group, will present on venture capital, term sheets and the terms of a transaction. 

Key Takeaways: 

  • Understanding key concepts for ‘Term Sheets’ and ‘Letters of Intent’
  • A look at various investment types, including equity, debt investments, early stage equity financing transactions and 'Convertible Preferred Stock'
  • Common provisions in a term sheet
  • Negotiation tips and strategies for success
Back to Page